StonvexLoading…
StonvexStonvexStonvexCore line items from CRDO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-06-03 | Q1 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Annual 2025 2025-05-03 |
|---|---|---|---|---|---|
Revenue | $440.69M | $898.11M | $491.10M | $223.07M | $436.77M |
Operating Income | Not available | $289.16M | $139.54M | $60.74M | $37.12M |
Net Income | Not available | $303.18M | $146.03M | $63.40M | $52.18M |
EPS (Diluted) | $1.05 | $1.62 | $0.79 | $0.34 | $0.29 |
Total Assets | Not available | $2.04B | $1.45B | $905.17M | $809.26M |
Total Liabilities | Not available | $188.45M | $163.20M | $123.79M | $127.67M |
Cash & Equivalents | Not available | $1.22B | $567.58M | $219.64M | $236.33M |
Free Cash Flow OCF − CapEx | Not available | $229.53M | $89.82M | $51.35M | $29.02M |
Shares Outstanding | Not available | 184.22M | 178.52M | 172.90M | 171.17M |